Globus Medical, Inc.
GMED
$91.70
-$2.10-2.24%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 422.28% | 363.08% | 776.83% | 178.51% | -16.19% |
| Total Depreciation and Amortization | 9.26% | 6.82% | 19.00% | 45.11% | 75.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.89% | -85.45% | -86.80% | 82.47% | 183.08% |
| Change in Net Operating Assets | 31.53% | 89.41% | 107.30% | 67.27% | 16.33% |
| Cash from Operations | 44.72% | 72.35% | 155.60% | 166.13% | 113.82% |
| Capital Expenditure | -42.67% | -11.88% | -40.63% | -35.35% | -47.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,332.07% | -1,332.07% | 18.74% | 98.37% | 94.04% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 244.72% | -89.56% | -81.91% | -79.78% | -106.35% |
| Cash from Investing | -101.65% | -239.81% | -256.91% | -99.22% | -158.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -18.73% | 128.18% | 394.35% | 979.80% | 790.85% |
| Repurchase of Common Stock | -227.90% | 20.95% | 32.65% | 39.48% | 60.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 65.87% | 49.26% | 48.42% | 47.99% | -467.47% |
| Cash from Financing | -2,352.20% | -94.84% | -69.46% | -56.18% | 88.05% |
| Foreign Exchange rate Adjustments | 8,701.96% | 237.63% | 691.99% | 742.50% | -88.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.44% | -173.15% | -274.06% | -21.39% | 0.10% |